S&P 500   4,253.54 (+0.57%)
DOW   33,107.55 (+0.32%)
QQQ   358.93 (+1.13%)
AAPL   173.04 (+0.37%)
MSFT   318.18 (+1.53%)
META   305.59 (+1.55%)
GOOGL   134.99 (+1.93%)
AMZN   126.02 (+1.04%)
TSLA   256.53 (+4.06%)
NVDA   439.04 (+0.89%)
NIO   8.74 (+1.51%)
BABA   84.19 (-0.41%)
AMD   102.30 (+2.22%)
T   14.56 (-1.49%)
F   12.05 (-0.17%)
MU   67.75 (-0.12%)
CGC   0.76 (+11.96%)
GE   108.85 (+1.01%)
DIS   79.31 (-0.29%)
AMC   8.05 (+2.55%)
PFE   33.61 (-0.86%)
PYPL   58.26 (+1.68%)
NFLX   379.00 (+0.60%)
S&P 500   4,253.54 (+0.57%)
DOW   33,107.55 (+0.32%)
QQQ   358.93 (+1.13%)
AAPL   173.04 (+0.37%)
MSFT   318.18 (+1.53%)
META   305.59 (+1.55%)
GOOGL   134.99 (+1.93%)
AMZN   126.02 (+1.04%)
TSLA   256.53 (+4.06%)
NVDA   439.04 (+0.89%)
NIO   8.74 (+1.51%)
BABA   84.19 (-0.41%)
AMD   102.30 (+2.22%)
T   14.56 (-1.49%)
F   12.05 (-0.17%)
MU   67.75 (-0.12%)
CGC   0.76 (+11.96%)
GE   108.85 (+1.01%)
DIS   79.31 (-0.29%)
AMC   8.05 (+2.55%)
PFE   33.61 (-0.86%)
PYPL   58.26 (+1.68%)
NFLX   379.00 (+0.60%)
S&P 500   4,253.54 (+0.57%)
DOW   33,107.55 (+0.32%)
QQQ   358.93 (+1.13%)
AAPL   173.04 (+0.37%)
MSFT   318.18 (+1.53%)
META   305.59 (+1.55%)
GOOGL   134.99 (+1.93%)
AMZN   126.02 (+1.04%)
TSLA   256.53 (+4.06%)
NVDA   439.04 (+0.89%)
NIO   8.74 (+1.51%)
BABA   84.19 (-0.41%)
AMD   102.30 (+2.22%)
T   14.56 (-1.49%)
F   12.05 (-0.17%)
MU   67.75 (-0.12%)
CGC   0.76 (+11.96%)
GE   108.85 (+1.01%)
DIS   79.31 (-0.29%)
AMC   8.05 (+2.55%)
PFE   33.61 (-0.86%)
PYPL   58.26 (+1.68%)
NFLX   379.00 (+0.60%)
S&P 500   4,253.54 (+0.57%)
DOW   33,107.55 (+0.32%)
QQQ   358.93 (+1.13%)
AAPL   173.04 (+0.37%)
MSFT   318.18 (+1.53%)
META   305.59 (+1.55%)
GOOGL   134.99 (+1.93%)
AMZN   126.02 (+1.04%)
TSLA   256.53 (+4.06%)
NVDA   439.04 (+0.89%)
NIO   8.74 (+1.51%)
BABA   84.19 (-0.41%)
AMD   102.30 (+2.22%)
T   14.56 (-1.49%)
F   12.05 (-0.17%)
MU   67.75 (-0.12%)
CGC   0.76 (+11.96%)
GE   108.85 (+1.01%)
DIS   79.31 (-0.29%)
AMC   8.05 (+2.55%)
PFE   33.61 (-0.86%)
PYPL   58.26 (+1.68%)
NFLX   379.00 (+0.60%)
OTCMKTS:CGNH

CardioGenics (CGNH) Stock Forecast, Price & News

Compare
Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
N/A
Average Volume
645 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

CGNH stock logo

About CardioGenics (OTCMKTS:CGNH) Stock

CardioGenics Holdings Inc. engages in the development and commercialization of diagnostic test products for the in vitro diagnostics testing market in the United States, Canada, Europe, and internationally. Its products include QL Care Analyzer, a portable, stand-alone, and automated point-of-care (POC) immunoassay analyzer that uses a proprietary self-metering cartridge to perform immunoassay tests at the POC; a series of immunoassay tests to identify cardiac markers in the blood at the time of a heart attack; and paramagnetic beads that are used as solid surfaces in heterogeneous immunoassay tests by clinical and research laboratories. The company was formerly known as Jag Media Holdings, Inc. and changed its name to CardioGenics Holdings Inc. in 2009. The company was founded in 1997 and is headquartered in Mississauga, Canada.


CGNH Stock News Headlines

New Breakthrough "Living Software" Has Been…
New Breakthrough "Living Software" Has Been... Ukraine's "Secret Weapon" Against Russia The Washington Post Reports: "It's a big reason David is beating Goliath..." The Wall Street Journal Reports: "it's a technical revolution." Jeff Bezos Said: "It's in the realm of science fiction." Early investors can reap 5,633% gains on the small company revolutionizing warfare >>>
Cardiogenics Holdings Inc (CGNH)
New Breakthrough "Living Software" Has Been…
New Breakthrough "Living Software" Has Been... Ukraine's "Secret Weapon" Against Russia The Washington Post Reports: "It's a big reason David is beating Goliath..." The Wall Street Journal Reports: "it's a technical revolution." Jeff Bezos Said: "It's in the realm of science fiction." Early investors can reap 5,633% gains on the small company revolutionizing warfare >>>
CardioGenics Holdings Inc.
See More Headlines
Receive CGNH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for CardioGenics and its competitors with MarketBeat's FREE daily newsletter.

CGNH Company Calendar

Today
10/04/2023
Fiscal Year End
10/31/2023

Industry, Sector and Symbol

Industry
Business services, not elsewhere classified
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:CGNH
Employees
4
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
1.05
Beginner's Guide to Pot Stock Investing Cover

Click the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise.

Get This Free Report

Key Executives

  • Dr. Yahia Abdul Gawad (Age 65)
    Founder, CEO & Director
  • Mr. James A. Essex CA (Age 74)
    MBA, Chief Financial Officer
  • Ms. Linda J. Sterling F.Inst.L.C.O. (Age 62)
    Corp. Sec. & Director













CGNH Stock - Frequently Asked Questions

What other stocks do shareholders of CardioGenics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other CardioGenics investors own include Trinity Biotech (TRIB), Rock Creek Pharmaceuticals (RCPIQ),

What is CardioGenics' stock symbol?

CardioGenics trades on the OTCMKTS under the ticker symbol "CGNH."

How do I buy shares of CardioGenics?

Shares of CGNH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

How can I contact CardioGenics?

CardioGenics' mailing address is 6295 Northam Drive Unit 8, Mississauga A6, L4V 1W8. The official website for the company is www.cardiogenics.com. The company can be reached via phone at (905) 673-8501, via email at invest@jagnotes.com, or via fax at 905-673-9865.

This page (OTCMKTS:CGNH) was last updated on 10/4/2023 by MarketBeat.com Staff

My Account -